← FDA DRUG APPROVALS

FDA ANDA · ANDA065134

DOXYCYCLINE HYCLATE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA065134
TYPE
ANDA
ORIGINAL APPROVAL
2005-05-13
LATEST ACTION
2025-04-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DOXYCYCLINE HYCLATEPrescription
DOXYCYCLINE HYCLATE EQ 20MG BASE · TABLET · ORAL

Approval history

2025-04-01Labeling · Supplement 22 · standardAP
2010-01-19Labeling · Supplement 8AP
2005-05-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →